In fact, the data showed ER homeostasis disruption in tumor cells, since expressions of some genes of UPR and GRP78/GADD153 protein levels were elevated by Amblyomin-X treatment, as well as ATF-6α transport. The gene discussed is DDIT3; the disease is neoplasm.